Cortisol is a steroid hormone in the glucocorticoid class of hormones and a stress hormone. When used as medication, it is known as hydrocortisone. Chemically it is a 21-carbon corticosteroid with formula C21H30O5 and a molecular weight of about 362.5 g mol; it is synthesized in the zona fasciculata of the adrenal cortex under control of the hypothalamic-pituitary-adrenal axis with adrenocorticotropic hormone as the principal stimulatory signal. Cortisol circulates largely bound to corticosteroid-binding globulin and albumin with a small free fraction that is biologically active. Peripheral activation and inactivation are mediated by 11-beta-hydroxysteroid dehydrogenase type 1 and type 2 respectively, permitting tissue-specific modulation. At target cells cortisol binds the glucocorticoid receptor to produce genomic effects via transcriptional regulation and also elicits rapid non genomic responses; physiological roles include regulation of glucose metabolism, immune function, vascular reactivity and circadian timing. Pharmacologically hydrocortisone is used for adrenal replacement therapy, anti-inflammatory and immunosuppressive indications; common analytical methods for cortisol and hydrocortisone include HPLC, LC-MS MS and GC-MS.
Parent: Cortisol
Parent: Hydrocortisone / Cortisol
Technical specifications for hydrocortisone API typically require high assay purity and strict control of related substances and degradation products; typical assay limits for pharmaceutical grade material are greater than 98.0 percent active substance by validated HPLC assay. Typical acceptance criteria for individual related compounds are commonly in the range of 0.1 to 0.5 percent each, with total impurities usually limited to about 1.0 to 2.0 percent depending on the applicable monograph or regulatory filing. Representative related compounds and degradation products that are monitored include cortisone, 11-deoxycortisol, 6-beta-hydroxycortisol, prednisone and prednisolone if present as process-related species, and various oxidation products; typical individual limits are often set at less than 0.5 percent for these species and combined related substances may be restricted to less than 1.5 percent. Analytical control also covers residual solvents and elemental impurities according to ICH Q3C and Q3D limits, and stability testing evaluates hydrolytic and oxidative degradation under forced conditions to define shelf life and storage conditions.
High cortisol indicates an elevated circulating level of the hormone relative to an individual baseline or reference range; clinically this can reflect chronic activation of the hypothalamic-pituitary-adrenal axis from stress, exogenous glucocorticoid therapy, or pathologic causes such as Cushing syndrome due to an ACTH secreting pituitary adenoma, ectopic ACTH production, or adrenal cortisol-producing tumors. Elevated cortisol produces metabolic effects including hyperglycemia, central adiposity, muscle wasting, immune suppression and dysregulated blood pressure, and requires clinical evaluation with biochemical testing and imaging when persistent or symptomatic.
Lowering cortisol depends on the cause: for exogenous glucocorticoid excess the approach is careful tapering under medical supervision; for endogenous overproduction specific medical or surgical treatments target the source such as steroidogenesis inhibitors or tumor resection. Lifestyle measures that reduce chronic HPA axis activation include regular sleep with consistent timing, evidence based stress reduction techniques such as mindfulness and cognitive strategies, balanced nutrition with attention to glycemic stability, and avoidance of excessive stimulants like high dose caffeine. In acute severe hypercortisolemia pharmacologic inhibitors of cortisol synthesis such as ketoconazole, metyrapone or etomidate may be used in hospital settings; any pharmacologic or surgical intervention should be guided by an endocrinologist.
Cortisol modulates multiple systems: it promotes gluconeogenesis and mobilization of energy substrates, increases blood glucose and counteracts insulin, influences protein catabolism and fat redistribution, exerts potent anti-inflammatory and immunosuppressive effects via downregulation of proinflammatory gene expression, affects vascular tone and fluid balance, and helps coordinate the circadian and stress response. Tissue specificity is determined by local metabolism, receptor density and timing of exposure; both deficiency and excess of cortisol have significant clinical consequences.
Moderate intensity aerobic exercise such as brisk walking, cycling or swimming performed regularly is associated with reductions in baseline cortisol and improved stress resilience. Mind-body practices like yoga, tai chi and guided breathing consistently lower perceived stress and acute cortisol responses. Resistance training of moderate intensity also provides benefits when not combined with excessive volume or frequency that can chronically elevate cortisol. High intensity or prolonged exhaustive exercise can transiently raise cortisol, so programming that balances intensity, recovery and sleep is important to achieve net cortisol-lowering effects.
